AMGN34:BVMF
Amgen Inc. BDR
71,85 BRL
arrow_upward
+0,67%(+0,48) 1D
29 korr, 10:11:55 p.d., GMT-3 · BRL
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN34...
Hap
71,85 BRL
I lartë
71,85 BRL
I ulët
71,85 BRL
Kapitalizimi i tregut
210,43 mld
Vëllimi mesatar
485,00
Vëllimi
45,00
Maksimumi 52-javor
77,39 BRL
Minimumi 52-javor
47,94 BRL
Aksionet në qarkullim
539,71 mln
Numri i punonjësve
32 mijë
Hap
71,85 BRL
I lartë
71,85 BRL
I ulët
71,85 BRL
Kapitalizimi i tregut
210,43 mld
Vëllimi mesatar
485,00
Vëllimi
45,00
Maksimumi 52-javor
77,39 BRL
Minimumi 52-javor
47,94 BRL
Aksionet në qarkullim
539,71 mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet nëpër ueb
Simply Wall St
·
4 orë më parë
Amgen (AMGN) Stock Could Be A Bargain On Cash Flow But Fairly Priced On Earnings
MarketBeat
·
4 orë më parë
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Barclays Analyst Says
scanx.trade
·
18 orë më parë
Amgen Q2 Results: Earnings call set for Aug 4 with CEO Bradway
Yahoo Finance
·
19 orë më parë
AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc. BDR
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më8 pri 1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiamgen.com
Përmbajtjet me IA mund të përfshijnë gabime. Mëso më shumë